Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Perphenazine is a typical antipsychotic drug. Chemically, it is classified as a piperazinyl phenothiazine. Originally marketed in the US as Trilafon, it has been in clinical use for decades. Perphenazine is roughly five times as potent as chlorpromazine, thus perphenazine is considered a medium-potency antipsychotic.
The global average price of Perphenazine is in the decreasing trend, from 6.95 USD/Unit in 2012 to 7.08 USD/Unit in 2016. With the situation of global economy, prices will be in increasing trend in the following five years.The classification of Perphenazine includes Oral Forms and Injectable Solution, and the proportion of Oral Forms in 2016 is about 98%.Perphenazine is widely used to treat psychosis and antiemetic. The most proportion of Perphenazine is used to treat psychosis, and the proportion in 2016 is 95%.North America is the largest consumption place, with a consumption market share nearly 39% in 2015. Following North America, Asia Pacific is the second largest consumption place with the consumption market share of 25%. Market competition is not intense. Teva, Sandoz, ZHPHARMA, Mylan, Endo, Shandong Boshan Pharma, etc. are the leaders of the industry, with high-end customers; have been formed in the monopoly position in the industry.
This report offers an overview of the market trends, drivers, and barriers with respect to the USA Perphenazine market. It also provides a detailed overview of the market of different regions across West USA, South USA, Middle West USA, Northeast USA. The report deeply analyzes type and application in the USA Perphenazine market. Detailed analysis of key players, along with key growth strategies adopted by Perphenazine industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.
By Player:
Teva
Sandoz
ZHPHARMA
Mylan
Endo
Shandong Boshan Pharma
By Type:
Oral Forms
Injectable Solution
By End-User:
Psychosis
Antiemetic
By Region:
-
West USA
-
South USA
-
Middle West USA
-
Northeast USA
TABLE OF CONTENT
1 Report Overview
-
1.1 Product Definition and Scope
-
1.2 PEST (Political, Economic, Social and Technological) Analysis of Perphenazine Market
-
1.3 Market Segment by Type
-
1.3.1 USA Perphenazine Market Size and Growth Rate of Oral Forms from 2016 to 2027
-
1.3.2 USA Perphenazine Market Size and Growth Rate of Injectable Solution from 2016 to 2027
-
1.4 Market Segment by Application
-
1.4.1 USA Perphenazine Market Size and Growth Rate of Psychosis from 2016 to 2027
-
1.4.2 USA Perphenazine Market Size and Growth Rate of Antiemetic from 2016 to 2027
-
1.5 Market Segment by Regions
-
1.5.1 West USA Perphenazine Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.2 South USA Perphenazine Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.3 Middle West USA Perphenazine Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.4 Northeast USA Perphenazine Consumption Market Size and Growth Rate from 2016 to 2027
2 Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Market Challenges and Restraints
-
2.1.2 Market Opportunities and Potentials
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape Analysis
-
2.2.1 Industrial Concentration Analysis
-
2.2.2 Porter's Five Forces Analysis of the Industry
-
2.2.3 SWOT Analysis for New Entrants
-
2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry
3 Segmentation of Perphenazine Market by Types
-
3.1 Products Development Trends of Different Types
-
3.2 Products Types of Major Vendors
-
3.3 Competitive Landscape Analysis of Different Types
-
3.4 Market Size of Perphenazine by Major Types
-
3.4.1 Market Size and Growth Rate of Oral Forms
-
3.4.2 Market Size and Growth Rate of Injectable Solution
4 Segmentation of Perphenazine Market by End-Users
-
4.1 Downstream Client Analysis by End-Users
-
4.2 Competitive Landscape Analysis of Different End-Users
-
4.3 Market Potential Analysis of Different End-Users
-
4.4 Market Size of Perphenazine by Major End-Users
-
4.4.1 Market Size and Growth Rate of Perphenazine in Psychosis
-
4.4.2 Market Size and Growth Rate of Perphenazine in Antiemetic
5 Market Analysis by Regions
-
5.1 USA Perphenazine Production Analysis by Regions
-
5.2 USA Perphenazine Consumption Analysis by Regions
-
5.3 Coronavirus (COVID-19) Impact on USA Economy
6 West USA Perphenazine Landscape Analysis
-
6.1 West USA Perphenazine Landscape Analysis by Major Types
-
6.2 West USA Perphenazine Landscape Analysis by Major End-Users
7 South USA Perphenazine Landscape Analysis
-
7.1 South USA Perphenazine Landscape Analysis by Major Types
-
7.2 South USA Perphenazine Landscape Analysis by Major End-Users
8 Middle West USA Perphenazine Landscape Analysis
-
8.1 Middle West USA Perphenazine Landscape Analysis by Major Types
-
8.2 Middle West USA Perphenazine Landscape Analysis by Major End-Users
9 Northeast USA Perphenazine Landscape Analysis
-
9.1 Northeast USA Perphenazine Landscape Analysis by Major Types
-
9.2 Northeast USA Perphenazine Landscape Analysis by Major End-Users
10 Major Players Profiles
-
10.1 Teva
-
10.1.1 Teva Company Profile and Recent Development
-
10.1.2 Market Performance
-
10.1.3 Product and Service Introduction
-
10.2 Sandoz
-
10.2.1 Sandoz Company Profile and Recent Development
-
10.2.2 Market Performance
-
10.2.3 Product and Service Introduction
-
10.3 ZHPHARMA
-
10.3.1 ZHPHARMA Company Profile and Recent Development
-
10.3.2 Market Performance
-
10.3.3 Product and Service Introduction
-
10.4 Mylan
-
10.4.1 Mylan Company Profile and Recent Development
-
10.4.2 Market Performance
-
10.4.3 Product and Service Introduction
-
10.5 Endo
-
10.5.1 Endo Company Profile and Recent Development
-
10.5.2 Market Performance
-
10.5.3 Product and Service Introduction
-
10.6 Shandong Boshan Pharma
-
10.6.1 Shandong Boshan Pharma Company Profile and Recent Development
-
10.6.2 Market Performance
-
10.6.3 Product and Service Introduction
The List of Tables and Figures
-
Figure Product Picture
-
Figure USA Perphenazine Market Size and Growth Rate of Oral Forms from 2016 to 2027
-
Figure USA Perphenazine Market Size and Growth Rate of Injectable Solution from 2016 to 2027
-
Figure Market Share by Type in 2016
-
Figure Market Share by Type in 2020
-
Figure Market Share by Type in 2027
-
Figure USA Perphenazine Market Size and Growth Rate of Psychosis from 2016 to 2027
-
Figure USA Perphenazine Market Size and Growth Rate of Antiemetic from 2016 to 2027
-
Figure Market Share by End-User in 2016
-
Figure Market Share by End-User in 2020
-
Figure Market Share by End-User in 2027
-
Figure West USA Perphenazine Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure South USA Perphenazine Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Middle West USA Perphenazine Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Northeast USA Perphenazine Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Development Trends and Industry Dynamics of Perphenazine Industry
-
Figure Market Challenges and Restraints
-
Figure Market Opportunities and Potentials
-
Table Mergers and Acquisition
-
Figure Market Share of TOP 3 Players in 2019
-
Figure Market Share of TOP 5 Players in 2019
-
Figure Market Share of TOP 6 Players from 2016 to 2020
-
Figure Porter's Five Forces Analysis
-
Figure New Entrant SWOT Analysis
-
Figure Coronavirus (COVID-19) Distribution Map of USA
-
Table Coronavirus (COVID-19) Impact on the Industry
-
Figure Specifications of Different Types of Perphenazine
-
Figure Development Trends of Different Types
-
Table Products Types of Major Vendors
-
Figure Competitive Landscape Analysis of Different Types
-
Table Consumption of Perphenazine by Different Types from 2016 to 2027
-
Table Consumption Share of Perphenazine by Different Types from 2016 to 2027
-
Figure Market Size and Growth Rate of Oral Forms
-
Figure Market Size and Growth Rate of Injectable Solution
-
Table Downstream Client Analysis by End-Users
-
Figure Competitive Landscape Analysis of Different End-Users
-
Table Market Potential Analysis of Different End-Users
-
Figure Consumption of Perphenazine by Different End-Users from 2016 to 2027
-
Table Consumption Share of Perphenazine by Different End-Users from 2016 to 2027
-
Figure Market Size and Growth Rate of Psychosis
-
Figure Market Size and Growth Rate of Antiemetic
-
Table USA Perphenazine Production by Regions
-
Table USA Perphenazine Production Share by Regions
-
Figure USA Perphenazine Production Share by Regions in 2016
-
Figure USA Perphenazine Production Share by Regions in 2021
-
Figure USA Perphenazine Production Share by Regions in 2027
-
Table USA Perphenazine Consumption by Regions
-
Table USA Perphenazine Consumption Share by Regions
-
Figure USA Perphenazine Consumption Share by Regions in 2016
-
Figure USA Perphenazine Consumption Share by Regions in 2021
-
Figure USA Perphenazine Consumption Share by Regions in 2027
-
Table West USA Perphenazine Consumption by Types from 2016 to 2027
-
Table West USA Perphenazine Consumption Share by Types from 2016 to 2027
-
Figure West USA Perphenazine Consumption Share by Types in 2016
-
Figure West USA Perphenazine Consumption Share by Types in 2021
-
Figure West USA Perphenazine Consumption Share by Types in 2027
-
Table West USA Perphenazine Consumption by End-Users from 2016 to 2027
-
Table West USA Perphenazine Consumption Share by End-Users from 2016 to 2027
-
Figure West USA Perphenazine Consumption Share by End-Users in 2016
-
Figure West USA Perphenazine Consumption Share by End-Users in 2021
-
Figure West USA Perphenazine Consumption Share by End-Users in 2027
-
Table South USA Perphenazine Consumption by Types from 2016 to 2027
-
Table South USA Perphenazine Consumption Share by Types from 2016 to 2027
-
Figure South USA Perphenazine Consumption Share by Types in 2016
-
Figure South USA Perphenazine Consumption Share by Types in 2021
-
Figure South USA Perphenazine Consumption Share by Types in 2027
-
Table South USA Perphenazine Consumption by End-Users from 2016 to 2027
-
Table South USA Perphenazine Consumption Share by End-Users from 2016 to 2027
-
Figure South USA Perphenazine Consumption Share by End-Users in 2016
-
Figure South USA Perphenazine Consumption Share by End-Users in 2021
-
Figure South USA Perphenazine Consumption Share by End-Users in 2027
-
Table Middle West USA Perphenazine Consumption by Types from 2016 to 2027
-
Table Middle West USA Perphenazine Consumption Share by Types from 2016 to 2027
-
Figure Middle West USA Perphenazine Consumption Share by Types in 2016
-
Figure Middle West USA Perphenazine Consumption Share by Types in 2021
-
Figure Middle West USA Perphenazine Consumption Share by Types in 2027
-
Table Middle West USA Perphenazine Consumption by End-Users from 2016 to 2027
-
Table Middle West USA Perphenazine Consumption Share by End-Users from 2016 to 2027
-
Figure Middle West USA Perphenazine Consumption Share by End-Users in 2016
-
Figure Middle West USA Perphenazine Consumption Share by End-Users in 2021
-
Figure Middle West USA Perphenazine Consumption Share by End-Users in 2027
-
Table Northeast USA Perphenazine Consumption by Types from 2016 to 2027
-
Table Northeast USA Perphenazine Consumption Share by Types from 2016 to 2027
-
Figure Northeast USA Perphenazine Consumption Share by Types in 2016
-
Figure Northeast USA Perphenazine Consumption Share by Types in 2021
-
Figure Northeast USA Perphenazine Consumption Share by Types in 2027
-
Table Northeast USA Perphenazine Consumption by End-Users from 2016 to 2027
-
Table Northeast USA Perphenazine Consumption Share by End-Users from 2016 to 2027
-
Figure Northeast USA Perphenazine Consumption Share by End-Users in 2016
-
Figure Northeast USA Perphenazine Consumption Share by End-Users in 2021
-
Figure Northeast USA Perphenazine Consumption Share by End-Users in 2027
-
Table Company Profile and Development Status of Teva
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Teva
-
Figure Sales and Growth Rate Analysis of Teva
-
Figure Revenue and Market Share Analysis of Teva
-
Table Product and Service Introduction of Teva
-
Table Company Profile and Development Status of Sandoz
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sandoz
-
Figure Sales and Growth Rate Analysis of Sandoz
-
Figure Revenue and Market Share Analysis of Sandoz
-
Table Product and Service Introduction of Sandoz
-
Table Company Profile and Development Status of ZHPHARMA
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of ZHPHARMA
-
Figure Sales and Growth Rate Analysis of ZHPHARMA
-
Figure Revenue and Market Share Analysis of ZHPHARMA
-
Table Product and Service Introduction of ZHPHARMA
-
Table Company Profile and Development Status of Mylan
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Mylan
-
Figure Sales and Growth Rate Analysis of Mylan
-
Figure Revenue and Market Share Analysis of Mylan
-
Table Product and Service Introduction of Mylan
-
Table Company Profile and Development Status of Endo
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Endo
-
Figure Sales and Growth Rate Analysis of Endo
-
Figure Revenue and Market Share Analysis of Endo
-
Table Product and Service Introduction of Endo
-
Table Company Profile and Development Status of Shandong Boshan Pharma
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Shandong Boshan Pharma
-
Figure Sales and Growth Rate Analysis of Shandong Boshan Pharma
-
Figure Revenue and Market Share Analysis of Shandong Boshan Pharma
-
Table Product and Service Introduction of Shandong Boshan Pharma
-
